McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
Mr. Brian Tyler is the Chief Executive Officer of McKesson Corp, joining the firm since 2012.
What is the price performance of MCK stock?
The current price of MCK is $877.02, it has increased 0% in the last trading day.
What are the primary business themes or industries for McKesson Corp?
McKesson Corp belongs to Health Care industry and the sector is Health Care
What is McKesson Corp market cap?
McKesson Corp's current market cap is $107.4B
Is McKesson Corp a buy, sell, or hold?
According to wall street analysts, 18 analysts have made analyst ratings for McKesson Corp, including 7 strong buy, 11 buy, 4 hold, 0 sell, and 7 strong sell